Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
For Most Patients, Factor Replacement Likely Unnecessary Up to 25 Years After Gene Therapy for Hemophilia B
03/02/2023
Jolynn Tumolo
Predictive analyses suggest a majority of patients with hemophilia B likely would achieve durable clotting factor levels after a single infusion of etranacogene dezaparvovec.
Predictive analyses suggest a majority of patients with hemophilia B likely would achieve durable clotting factor levels after a single infusion of etranacogene dezaparvovec.
Predictive analyses suggest a...
03/02/2023
First Report Managed Care
News
Too Many Patients Receiving Too Little Rehab After Stroke, Study Finds
03/02/2023
Jolynn Tumolo
Rates of physical, occupational, and speech rehabilitation therapy after stroke are low in the United States, according to study findings published in Stroke.
Rates of physical, occupational, and speech rehabilitation therapy after stroke are low in the United States, according to study findings published in Stroke.
Rates of physical, occupational,...
03/02/2023
Neurology
News
Majority of Assisted Living Residents Dually Eligible for Medicare, Medicaid Live in Minority of Facilities
03/01/2023
Jolynn Tumolo
“Future research is warranted to evaluate assisted living care quality by the distribution of dually eligible adults,” researchers said.
“Future research is warranted to evaluate assisted living care quality by the distribution of dually eligible adults,” researchers said.
“Future research is warranted to...
03/01/2023
Annals of Long-Term Care
News
Two Type 2 Inflammation Markers Elevated in Patients With Prurigo Nodularis
03/01/2023
Jolynn Tumolo
“Given the diversity of this disease, further biomarker studies may help elucidate future precision medicine approaches in the management of prurigo nodularis," researchers advised.
“Given the diversity of this disease, further biomarker studies may help elucidate future precision medicine approaches in the management of prurigo nodularis," researchers advised.
“Given the diversity of this...
03/01/2023
First Report Managed Care
News
DNA Methylation Influences Gene, Protein Expression Networks in Alzheimer Disease
03/01/2023
Jolynn Tumolo
DNA methylation has an impact on the gene and protein co-expression networks underlying Alzheimer disease, according to new study results.
DNA methylation has an impact on the gene and protein co-expression networks underlying Alzheimer disease, according to new study results.
DNA methylation has an impact on...
03/01/2023
Psych Congress Network
News
Biosimilar Matches Reference Natalizumab for Efficacy, Safety in Relapsing-Remitting MS
02/28/2023
Jolynn Tumolo
The proposed biosimilar natalizumab matches reference natalizumab for efficacy, safety, and immunogenicity in patients with relapsing-remitting MS.
The proposed biosimilar natalizumab matches reference natalizumab for efficacy, safety, and immunogenicity in patients with relapsing-remitting MS.
The proposed biosimilar...
02/28/2023
Neurology
News
No Notable Rise in Psychosis Diagnoses, Prescriptions in States That Legalized Cannabis
02/27/2023
Jolynn Tumolo
State policies legalizing cannabis are not associated with a statistically significant increase in rates of psychosis-related health outcomes, study finds.
State policies legalizing cannabis are not associated with a statistically significant increase in rates of psychosis-related health outcomes, study finds.
State policies legalizing...
02/27/2023
Psych Congress Network
News
Post-Hospitalization Costs Highest in Early Months in Older Adults With Multimorbidity
02/27/2023
Jolynn Tumolo
“Overall, our results indirectly support the importance of prevention and action before health status deteriorates (eg, promoting safety measures to reduce falls),” researchers wrote.
“Overall, our results indirectly support the importance of prevention and action before health status deteriorates (eg, promoting safety measures to reduce falls),” researchers wrote.
“Overall, our results indirectly...
02/27/2023
Annals of Long-Term Care
News
Reports of Cognitive Decline in Patients With MS Require Multidisciplinary Assessment
02/27/2023
Jolynn Tumolo
Only two-thirds of patients who reported cognitive decline actually showed cognitive impairment during testing, signaling the importance of extensive neurological evaluations, researchers said.
Only two-thirds of patients who reported cognitive decline actually showed cognitive impairment during testing, signaling the importance of extensive neurological evaluations, researchers said.
Only two-thirds of patients who...
02/27/2023
Veterans Health Today
News
Plasma Biomarker Predicts Cognitive Decline in Preclinical Alzheimer Disease
02/27/2023
Jolynn Tumolo
Plasma P-tau217 significantly predicted longitudinal cognitive decline in people with preclinical Alzheimer disease.
Plasma P-tau217 significantly predicted longitudinal cognitive decline in people with preclinical Alzheimer disease.
Plasma P-tau217 significantly...
02/27/2023
Neurology

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use